Essex Bio-Technology not rule out possibility of financing in Shenzhen

Ngiam Mia Je Patrick, chairman of Essex Bio-Technology (8151), said the stock displayed outstanding performance after getting listed in the morning, which was believed that it was the first listed bio-technology company in Hong Kong. Referring to whether the company would raise capital in Shenzhen market, he said the company would consider it only if it could bring financing convenience to the company, but no practical plans were worked out at the time being.

Related stock : (8151)